Where does Laboratoire Francais du Fractionnement et des Biotechnologies rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Laboratoire Francais du Fractionnement et des Biotechnologies ranks #4,956 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Laboratoire Francais du Fractionnement et des Biotechnologies's patent grant rate increasing or decreasing?

Laboratoire Francais du Fractionnement et des Biotechnologies's recent grant velocity is -64% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Laboratoire Francais du Fractionnement et des Biotechnologies's patents?

Laboratoire Francais du Fractionnement et des Biotechnologies's patents average 15.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Laboratoire Francais du Fractionnement et des Biotechnologies

Q: How is the Laboratoire Francais du Fractionnement et des Biotechnologies patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 70 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Laboratoire ranks #4,956 of 49,997 tracked US assignees by granted-patent volume, with 70 patents across 21 technology areas.

#4,956
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.7/100): 15.7
avg claims per patent: -64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4956 · Foreign Corporation #4,956 · 70 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 70 grants
TOP-DECILE #4,956/49,997
PHOTO-FINISH Johnson Health Tech
CPC-FOCUS C07K · 21 areas
INNOV-PAR 44.7/100
CLAIMS-RICH 15.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Johnson Health Tech Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Crocus Technology · near

45
Kiss Nail Products · near

45
Laboratoire… · this assignee

45
Mabuchi Motor · near

45
Sulzer Mixpac · near

45
3D Lighting… · lowest

7

What this shows Laboratoire's Innovation Score is 44.7/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Laboratoire's grants concentrate

Laboratoire Francais du Fractionnement et des Biotechnologies is a focused PatentsView assignee: 21 CPC subclasses with 72.9% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (12 grants) versus a trough of 2 in 2021. By volume, Laboratoire sits between Johnson Health Tech Co., Ltd. and Lowe's Companies, Inc..

Laboratoire's three-year grant acceleration

Laboratoire Francais du Fractionnement et des Biotechnologies shows 11 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Johnson Health Te…

70
Krohne

70
Lantiq Beteiligun…

70
Largan Digital

70
Lehigh University

70
Leica Biosystems…

70
Leica Instruments…

70
Lowe's Companies

70
Laboratoire Franc… ◀

70

What this shows Laboratoire holds 70 patents at rank #4,958, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Laboratoire

By rank, the assignees closest to #4,958 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Laboratoire's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Laboratoire, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Mabuchi Motor Co., Ltd. 45 Crocus Technology SA 45 Sulzer Mixpac AG 45 Kiss Nail Products, Inc. 45

Similar claim depth

Nearest assignees by average claims per patent (15.7 here).

Lindsay Corporation 15.7 avg Beijing BOE Chatani Electronics Co., Ltd. 15.7 avg UCL Business PLC 15.7 avg Dynamics Inc. 15.7 avg

Laboratoire's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Laboratoire Francais du Fractionnement et des Biotechnologies patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	12.9%
2016	10	14.3%
2017	12	17.1%
2018	9	12.9%
2019	10	14.3%
2020	5	7.1%
2021	2	2.9%
2022	2	2.9%
2023	6	8.6%
2024	3	4.3%
2025partial year	2	2.9%

Which technologies does Laboratoire Francais du Fractionnement et des Biotechnologies patent most?

C07K - Peptides 51

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 47

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 47

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 28

C12Y - Enzymes 14

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 9

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 5

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

B01D - Separation 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 15 of 21 technology areas

Where it ranks

Overall rank by patents

#4,956

of 49,997 tracked assignees

Innovation Score

44.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Laboratoire Francais du Fractionnement et des Biotechnologies's patent record in context - here's where to go next.

Laboratoire Francais du Fractionnement et des Biotechnologies's lead technology class is C07K (Peptides), 72.9% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #4,956 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Laboratoire Francais du Fractionnement et des Biotechnologies against Johnson Health Tech Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.